USAR USA Rare Earth, Inc.

Price Chart

Executive Summary

USA Rare Earth filed Amendment No. 1 to its S-3 shelf registration, registering up to 27.5M shares of common stock for primary issuance upon exercise of warrants and conversion of preferred stock, and up to 93.8M shares for secondary resale by selling stockholders. The resale shares represent ~35.2% of fully diluted shares, with selling stockholders acquiring shares at prices from <$0.01 to $21.50 vs. the $29.43 closing price on June 1, 2026, creating significant overhang risk. The company will receive proceeds only if Preferred Investor Warrants ($7.00 strike) are exercised for cash, with a maximum of ~$17.1M if all are exercised.

Actionable Insight

Key Facts

• Registers up to 27,514,143 primary shares (15,653,227 upon warrant exercise at assumed $1.00 strike; 11,860,916 upon Series A preferred conversion at assumed $1.00 conversion price)
• Registers up to 93,822,662 secondary resale shares by selling stockholders, representing ~35.2% of fully diluted shares
• Selling stockholders acquired shares at prices from <$0.01 to $21.50 per share; closing price on June 1, 2026 was $29.43
• Company would receive max ~$17.1M if all Preferred Investor Warrants exercised for cash at $7.00 per share; warrants can be exercised cashless
• 228,523,482 shares of common stock outstanding as of June 1, 2026
• Additional dilution from 16,132,790 shares and 17,600,584 warrant shares issuable to DOC under $1.6B Financing Arrangement
• Filing consolidates and replaces prior S-1 registration statements (333-287410 and 333-293172) under Rule 429

Financial Impact

Massive potential dilution: 93.8M secondary shares represent ~35.2% of fully diluted shares; primary issuance of up to 27.5M shares adds further dilution. Max cash proceeds to company of ~$17.1M if all warrants exercised, but likely minimal given cashless exercise option.

Risk Factors

• Massive secondary share overhang (~35.2% of fully diluted shares) from selling stockholders with very low cost basis
• Company receives no proceeds from secondary sales; primary warrant exercise likely cashless, yielding minimal cash
• Additional dilution from DOC-related shares (16.1M shares + 17.6M warrants) not yet registered
• Pre-revenue company with negative operating cash flows and no commercial production yet

Market Snapshot

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

US Market Status